Lymphoma Management Course

Our expert faculty of lymphoma specialists from across the UK provide a comprehensive overview of the diagnosis, treatment and management of lymphomas. Approved by RCPath for 12 CPD credits.

Book online (£320)       View the programme       I need an invoice

Lymphoma.Management.Promo.Accreditation

Got a question? Contact us: 01296 619 412 conferences@lymphoma-action.org.uk


Who should attend?

This course is ideal for specialist trainees, clinical nurse specialists, advanced nurse practitioners and consultants.


View the programme       View photos from the 2016-2019 courses

Learning outcomes:

Completion of the course should equip participants in the following areas:
• The principles underpinning diagnostic and therapeutic modalities as applied to lymphoma in all its subtypes
• An understanding of practical considerations when prescribing immunochemotherapy and radiotherapy
• To apply the most appropriate diagnostic techniques and therapeutic interventions to individual patients with a lymphoma diagnosis
• A thorough training in material which may be covered in professional exams e.g. FRCPath


About the venue:

Worcester College is situated in the heart of Oxford, with its many attractions and amenities, yet behind the college walls lie 26 acres of award-winning gardens and wooded grounds, including a lake, on-site sports fields, and an orchard. The college can be found on the junction of Beaumont Street, Walton Street and Worcester Street, just across the road from the main bus and coach station. It is less than a 10 minute walk from the railway station and main shopping areas. Download a map of Worcester College or go to Google street view to help find your way there.

Our conference will be based in the stunning Sultan Nazrin Shah Centre


About the organisers:

Dr Graham Collins is a Consultant Haematologist and lymphoma lead at the Oxford Cancer and Haematology Centre and Principle Investigator for a number of early and late phase studies. He is also the chair of the UK NIHR Hodgkin study group and T-cell working group.

 
Lymphoma is a fascinating disease, but it’s complicated, and developments are happening at a break neck pace. It is very important for all of us who look after lymphoma patients to spend some time out listening to data, discussing what the optimal ways of managing patients are in the context of the UK today. The Lymphoma Management Course has a great faculty of speakers from all over the UK and a number of different ways of teaching – lectures, breakout sessions, informal case discussions. Our aim is that at the end of the course we will have disseminated good practice and considered how we can improve outcomes for our patients.
Dr Graham Collins, Oxford

Dr Toby Eyre is a Consultant Haematologist at the Oxford Cancer and Haematology Centre with a specific interest in lymphoma and CLL. He is a member of the Low Grade lymphoma subgroup. He has a Diploma in Medical Education and a MD doctorate in early phase lymphoid clinical trials.

Lymphoma Action is the only charity in the UK specialising in lymphoma. The charity works closely with its medical advisors to provide educational events and resources for health professionals in addition to its primary role providing support and information to people affected by lymphoma.


Comments from the 2019 course:
  • In district hospitals the majority of patients are middle aged to advanced age, thus treatment eligibility and modifications are important to individualise. It was great to discuss this.
 
The most useful presentations were the disease specific ones which were all evidence based. It was helpful to find out how other centers are treating patients and what the future holds.
  • It was so nice to go on a course with an even mix of female and male presenters. I was very impressed with the quality of the presentations and experience of the presenters throughout both days.
  • Both DLBCL talks were an excellent and accessible summary of many complex trials .
  • Breakout sessions on flow cytometry and PTLD gave an opportunity to discuss cases in small groups, which is beneficial.
  • I enjoyed the practical sessions regarding management and future possibilities that may be coming .
 
I particularly found presentations which gave a background of lymphoma biology interesting. This was relevant in understanding new immunotherapy drugs and targeted treatments.
  • Dr Collins presentations were very interesting and engaging and a treat to listen to .
  • The sessions were pitched at a good level with relevant, but not overwhelming amounts of trial data .
  • DLBCL talk by Dr Cwynarski covered the patient journey, covered important questions asked in MDT and showed evidence base for current practice.
 
The informal case studies are great. It is reassuring that experienced doctors also experience doubt in some complicated cases. Or simple ones!
  • Thank you for the short, concise talks. They were effective in relaying information and I learnt so much.
  • I really enjoyed the way Dr Follows presented by highlighting controversies and then presenting the evidence underpinning them. Dr Collins and Dr Eyre were fantastic at bridging the talks and maintaining the interest and momentum during both days. I'd definitely recommend this course.logos